Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
388.78
Oct 20 • 3:59 PM ET Dollar change+4.87 Percentage change(1.27%)
Aftermarket Close
386.48
Aftermarket • 6:04 PM ET Dollar change-2.30 Percentage change(-0.59%)
Oct 19, 6:10 PMWest Pharmaceutical Services declares a fourth-quarter dividend of $0.26 per share, an 18% increase from the prior quarter and its 34th consecutive annual dividend raise.
Index
S&P 500
Market Cap
27.36B
Enterprise Value
27.24B
Income
564.90M
Sales
3.33B
Book/sh
42.47
Cash/sh
6.19
Employees
10800
IPO
Mar 17, 1980
P/E
49.70
Forward P/E
38.78
PEG
2.38
P/S
8.22
P/B
9.15
P/C
62.78
P/FCF
62.62
EV/EBITDA
29.86
EV/Sales
8.19
Quick Ratio
2.12
Current Ratio
2.82
Debt/Eq
0.11
LT Debt/Eq
0.10
Option/Short
Yes / Yes
EPS (ttm)
7.82
EPS next Y
10.03
EPS next Q
2.20
EPS this Y
23.15%
EPS next Y
11.68%
EPS next 5Y
16.27%
EPS past 3/5Y
-4.22% 8.26%
Sales past 3/5Y
2.14% 7.45%
EPS Y/Y TTM
17.07%
Sales Y/Y TTM
12.42%
EPS Q/Q
18.81%
Sales Q/Q
13.86%
Insider Own
0.75%
Insider Trans
-3.54%
Inst Own
102.59%
Inst Trans
-2.07%
ROA
14.07%
ROE
19.09%
ROIC
17.20%
Gross Margin
36.82%
Oper. Margin
21.97%
Profit Margin
16.98%
SMA20
4.06%
SMA50
8.15%
SMA200
26.07%
Trades
Shs Outstand
70.40M
Shs Float
69.85M
52W High
387.01 0.46%
52W Low
223.83 73.69%
Volatility
1.95% 2.26%
ATR (14)
8.19
RSI (14)
68.52
Beta
1.15
Rel Volume
0.94
Avg Volume
608.44K
Volume
570,226
Perf Week
4.56%
Perf Month
7.46%
Perf Quarter
8.47%
Perf Half Y
41.52%
Perf YTD
41.30%
Perf Year
41.43%
Perf 3Y
6.91%
Perf 5Y
-6.23%
Perf 10Y
436.32%
Prev Close
383.91
Price
388.78
Change %
1.27%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Favorite Annette FSr. VP & Chief HR OfficerSep 15 '26Option Exercise89.642,524226,25124,342Sep 15 04:37 PM
Favorite Annette FSr. VP & Chief HR OfficerSep 11 '26Option Exercise89.642,500224,10024,318Sep 15 04:37 PM
Favorite Annette FSr. VP & Chief HR OfficerSep 14 '26Option Exercise89.642,500224,10024,318Sep 15 04:37 PM
Favorite Annette FSr. VP & Chief HR OfficerSep 15 '26Sale365.002,524921,26021,818Sep 15 04:37 PM
Favorite Annette FSr. VP & Chief HR OfficerSep 14 '26Sale355.002,500887,50021,818Sep 15 04:37 PM
Favorite Annette FSr. VP & Chief HR OfficerSep 11 '26Sale345.002,500862,50021,818Sep 15 04:37 PM
Favorite Annette FSr. VP & Chief HR OfficerSep 08 '26Option Exercise85.378,135694,45319,663Sep 10 05:36 PM
Favorite Annette FSr. VP & Chief HR OfficerSep 08 '26Sale340.818,1352,772,48916,845Sep 10 05:36 PM
Hofmann Thomas WDirectorMay 07 '26Proposed Sale322.123,3841,090,051May 07 03:34 PM
Favorite Annette FSr. VP & Chief HR OfficerApr 27 '26Option Exercise83.472,817235,13519,645Apr 29 12:22 PM
Favorite Annette FSr. VP & Chief HR OfficerApr 27 '26Sale305.202,817859,75316,828Apr 29 12:22 PM
Winters ChadVP, Chief Accounting OfficerApr 27 '26Option Exercise173.22896155,2052,419Apr 29 12:19 PM
Winters ChadVP, Chief Accounting OfficerApr 27 '26Sale300.67896269,3991,523Apr 29 12:19 PM
West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions, drug delivery systems, analytical lab services, and other integrated services and solutions, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Senior VP & CFOMr. Robert W. McMahon C.M.A.
Chief HR Officer & Senior VPMs. Annette F. Favorite
SVP & Chief Proprietary Segment OfficerMr. Shane A. Campbell
PresidentMr. Michel Lagarde
VP of Finance & Chief Accounting OfficerMr. Chad R. Winters